Literature DB >> 25904355

Early surgical treatment benefits early staged pediatric moyamoya disease--single case report.

Go Matsuoka1, Yasuo Aihara, Koji Yamaguchi, Tatsuya Ishikawa, Akitsugu Kawashima, Takakazu Kawamata, Yoshikazu Okada.   

Abstract

PURPOSE: Surgical revascularization for pediatric moyamoya disease improves cerebral blood flow (CBF) and consequently may prevent further ischemic events. However, the timing of the treatment is controversial especially for patients with no ischemic symptom and normal CBF. The purpose of this case report is to inform and infer the surgical treatment timing for pediatric moyamoya disease patients. CASE REPORT: A 10-year-old female patient with unilateral moyamoya disease complaining of only headache as a symptom and whose Suzuki stage was II or in transition to III by angiography and CBF was almost normal was admitted to Tokyo Women's Medical University Hospital. We performed superficial temporal artery-middle cerebral artery (STA-MCA) double anastomoses for the patient because we estimated her headache was derived from low perfusion in the brain. STA-MCA bypass surgery was not only effective for relief of her severe headache but also valid for her cerebral perfusion. Her angiography showed much supply from external carotid artery to intracranial arteries via bypass grafts in 7 months.
CONCLUSION: Our case showed early surgical treatment was beneficial for relief of severe headache even for early staged pediatric moyamoya disease patients by improving perfusion pressure and cerebral circulation.

Entities:  

Mesh:

Year:  2015        PMID: 25904355     DOI: 10.1007/s00381-015-2709-3

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  20 in total

1.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

2.  Natural history and progression factors of unilateral moyamoya disease in pediatric patients.

Authors:  Eun Kyung Park; Yun-Ho Lee; Kyu-Won Shim; Joong-Uhn Choi; Dong-Seok Kim
Journal:  Childs Nerv Syst       Date:  2011-05-07       Impact factor: 1.475

Review 3.  Moyamoya disease: functional and neurocognitive outcomes in the pediatric and adult populations.

Authors:  David G Weinberg; Rudy J Rahme; Salah G Aoun; H Hunt Batjer; Bernard R Bendok
Journal:  Neurosurg Focus       Date:  2011-06       Impact factor: 4.047

4.  Effective surgical revascularization improves cerebral hemodynamics and resolves headache in pediatric Moyamoya disease.

Authors:  Masahito Kawabori; Satoshi Kuroda; Naoki Nakayama; Kenji Hirata; Toru Shiga; Kiyohiro Houkin; Nagara Tamaki
Journal:  World Neurosurg       Date:  2012-09-25       Impact factor: 2.104

5.  [Clinical features and outcomes in patients with asymptomatic moyamoya disease--from the results of nation-wide questionnaire survey].

Authors:  Masaru Yamada; Kiyotaka Fujii; Masashi Fukui
Journal:  No Shinkei Geka       Date:  2005-04

6.  Is "unilateral" moyamoya disease different from moyamoya disease?

Authors:  K Houkin; H Abe; T Yoshimoto; A Takahashi
Journal:  J Neurosurg       Date:  1996-11       Impact factor: 5.115

7.  Moyamoya disease--a review.

Authors:  J Suzuki; N Kodama
Journal:  Stroke       Date:  1983 Jan-Feb       Impact factor: 7.914

8.  Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.

Authors:  R Michael Scott; Jodi L Smith; Richard L Robertson; Joseph R Madsen; Sulpicio G Soriano; Mark A Rockoff
Journal:  J Neurosurg       Date:  2004-02       Impact factor: 5.115

9.  Follow-up study of patients with "unilateral" moyamoya disease.

Authors:  T Kawano; M Fukui; N Hashimoto; Y Yonekawa
Journal:  Neurol Med Chir (Tokyo)       Date:  1994-11       Impact factor: 1.742

10.  Determinants of intellectual outcome after surgical revascularization in pediatric moyamoya disease: a multivariate analysis.

Authors:  Satoshi Kuroda; Kiyohiro Houkin; Tatsuya Ishikawa; Naoki Nakayama; Jun Ikeda; Nobuaki Ishii; Hiroyasu Kamiyama; Yoshinobu Iwasaki
Journal:  Childs Nerv Syst       Date:  2004-03-24       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.